1
ALL1
KVK.TechYear
1
ALL1
2024DEALS // DEV.
1
ALL1
DealsCountry
1
ALL1
U.S.A1
ALL1
MedixTherapeutic Area
1
ALL1
Nutrition and Weight LossStudy Phase
1
ALL1
Approved FDFDeal Type
1
ALL1
PartnershipProduct Type
1
ALL1
Other Small MoleculeDosage Form
1
ALL1
UndisclosedLead Product
1
ALL1
Phentermine HydrochlorideTarget
1
ALL1
UndisclosedLead Product(s) : Phentermine Hydrochloride
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Medix
Deal Size : Undisclosed
Deal Type : Partnership
KVK Tech’s Lomaira Completes Registration in Mexico Through Partner Medix
Details : Through the partnership, Medix will gain the exclusive rights to manufacture, distribute, and market Lomaira (Phentermine Hydrochloride) in Mexico. It is indicated for the treatment of obesity.
Product Name : Lomaira
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
July 31, 2024
Lead Product(s) : Phentermine Hydrochloride
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Medix
Deal Size : Undisclosed
Deal Type : Partnership